These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 33003518)

  • 1. Dietary Factors and Supplements Influencing Prostate Specific-Antigen (PSA) Concentrations in Men with Prostate Cancer and Increased Cancer Risk: An Evidence Analysis Review Based on Randomized Controlled Trials.
    Grammatikopoulou MG; Gkiouras K; Papageorgiou SΤ; Myrogiannis I; Mykoniatis I; Papamitsou T; Bogdanos DP; Goulis DG
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 33003518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.
    Cicero AFG; Allkanjari O; Busetto GM; Cai T; Larganà G; Magri V; Perletti G; Robustelli Della Cuna FS; Russo GI; Stamatiou K; Trinchieri A; Vitalone A
    Arch Ital Urol Androl; 2019 Oct; 91(3):. PubMed ID: 31577095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
    Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P
    Prostate; 2015 Aug; 75(11):1177-86. PubMed ID: 25893930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary supplements and prostate cancer: a systematic review of double-blind, placebo-controlled randomised clinical trials.
    Posadzki P; Lee MS; Onakpoya I; Lee HW; Ko BS; Ernst E
    Maturitas; 2013 Jun; 75(2):125-30. PubMed ID: 23567264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ProDiet: A Phase II Randomized Placebo-controlled Trial of Green Tea Catechins and Lycopene in Men at Increased Risk of Prostate Cancer.
    Lane JA; Er V; Avery KNL; Horwood J; Cantwell M; Caro GP; Crozier A; Smith GD; Donovan JL; Down L; Hamdy FC; Gillatt D; Holly J; Macefield R; Moody H; Neal DE; Walsh E; Martin RM; Metcalfe C
    Cancer Prev Res (Phila); 2018 Nov; 11(11):687-696. PubMed ID: 30309839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing diseases of the prostate in the elderly using hormones and nutriceuticals.
    Comhaire F; Mahmoud A
    Aging Male; 2004 Jun; 7(2):155-69. PubMed ID: 15672940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phytotherapy for benign prostatic hyperplasia.
    Wilt TJ; Ishani A; Rutks I; MacDonald R
    Public Health Nutr; 2000 Dec; 3(4A):459-72. PubMed ID: 11276294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lycopene for the prevention and treatment of benign prostatic hyperplasia and prostate cancer: a systematic review.
    Ilic D; Misso M
    Maturitas; 2012 Aug; 72(4):269-76. PubMed ID: 22633187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phytotherapeutic interventions in the management of biochemically recurrent prostate cancer: a systematic review of randomised trials.
    van Die MD; Bone KM; Emery J; Williams SG; Pirotta MV; Paller CJ
    BJU Int; 2016 Apr; 117 Suppl 4(Suppl 4):17-34. PubMed ID: 26898239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of herbal and over-the-counter dietary supplements for the prevention of prostate cancer.
    Bemis DL; Capodice JL; Costello JE; Vorys GC; Katz AE; Buttyan R
    Curr Urol Rep; 2006 May; 7(3):166-74. PubMed ID: 16630519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary antioxidants and prostate cancer: a review.
    Vance TM; Su J; Fontham ET; Koo SI; Chun OK
    Nutr Cancer; 2013; 65(6):793-801. PubMed ID: 23909722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk.
    Bunker CH; McDonald AC; Evans RW; de la Rosa N; Boumosleh JM; Patrick AL
    Nutr Cancer; 2007; 57(2):130-7. PubMed ID: 17571945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer.
    Dalais FS; Meliala A; Wattanapenpaiboon N; Frydenberg M; Suter DA; Thomson WK; Wahlqvist ML
    Urology; 2004 Sep; 64(3):510-5. PubMed ID: 15351581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of green tea catechins in patients with high-grade prostatic intraepithelial neoplasia: Results of a short-term double-blind placebo controlled phase II clinical trial.
    Micali S; Territo A; Pirola GM; Ferrari N; Sighinolfi MC; Martorana E; Navarra M; Bianchi G
    Arch Ital Urol Androl; 2017 Oct; 89(3):197-202. PubMed ID: 28969404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutrition, dietary supplements and adenocarcinoma of the prostate.
    Schultz C; Meier M; Schmid HP
    Maturitas; 2011 Dec; 70(4):339-42. PubMed ID: 22001108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial.
    Meyer F; Galan P; Douville P; Bairati I; Kegle P; Bertrais S; Estaquio C; Hercberg S
    Int J Cancer; 2005 Aug; 116(2):182-6. PubMed ID: 15800922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomized controlled trials.
    van Die MD; Bone KM; Williams SG; Pirotta MV
    BJU Int; 2014 May; 113(5b):E119-30. PubMed ID: 24053483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer chemoprevention: Strategies for designing efficient clinical trials.
    Lieberman R
    Urology; 2001 Apr; 57(4 Suppl 1):224-9. PubMed ID: 11295633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence.
    Van Patten CL; de Boer JG; Tomlinson Guns ES
    J Urol; 2008 Dec; 180(6):2314-21; discussion 2721-2. PubMed ID: 18930254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: Elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia.
    Clark LC; Marshall JR
    Urology; 2001 Apr; 57(4 Suppl 1):185-7. PubMed ID: 11295623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.